logo
Select company
Select metric
$ 6.85MNet Cash Flow - Financing
VS
Market
36
Sector
49
Industry
59
History
50
$ 1.56Close
$ 1.24 - $ 11.05 52-Week Range
Ticker Information

Ticker

SXTP

Company Name

60 DEGREES PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

60 DEGREES PHARMACEUTICALS INC - Net Cash Flow - Financing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SXTP - CF - Financing Historical data
DateNet Cash Flow - Financing
6/30/2025$ 6.85M
3/31/2025$ 6.85M
12/31/2024$ 7.05M
9/30/2024$ 7.05M
6/30/2024$ 7.87M
3/31/2024$ 8.2M
12/31/2023$ 6.47M
12/31/2022$ 1.22M
12/31/2021$ 611.23K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • 60 DEGREES PHARMACEUTICALS INC's latest trailing twelve months (TTM) CF - Financing stands at $ 611.23K.
  • Over the past 5 years, 60 DEGREES PHARMACEUTICALS INC's average CF - Financing has been $ 5.8M.
  • The median CF - Financing for 60 DEGREES PHARMACEUTICALS INC during this period was $ 6.85M
  • 60 DEGREES PHARMACEUTICALS INC reached its highest CF - Financing over the past 5 years at $ 8.2M.
  • The lowest CF - Financing recorded by 60 DEGREES PHARMACEUTICALS INC in the same timeframe $ 611.23K

60 DEGREES PHARMACEUTICALS INC's CF - Financing vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Financing Benchmarks
CompanyCF - Financing
SPRB : SPRUCE BIOSCIENCES INC $ -1.84MONCO : ONCONETIX INC $ 5.5MAPRE : APREA THERAPEUTICS INC $ 573.98KVIVS : VIVOSIM LABS INC $ 4.28MPTIX : PROTAGENIC THERAPEUTICS INC $ 6.44MSLXN : SILEXION THERAPEUTICS CORP $ 12.34MTCRT : ALAUNOS THERAPEUTICS INC $ 0VYNE : VYNE THERAPEUTICS INC $ -255KKTTA : PASITHEA THERAPEUTICS CORP $ 11.73MADTX : ADITXT INC $ 29.27M

Definition of Net Cash Flow - Financing

[Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.

SXTP - Net Cash Flow - Financing, Last 5 years

$ 611.23K

Minimum

Dec 31, 2021

$ 8.2M

Maximum

Mar 31, 2024

$ 5.8M

Average

$ 6.85M

Median

CF - Financing Benchmark Analysis

The chart above depicts the distribution of CF - Financing for companies in the Total Stock Market. The average CF - Financing of the companies is $ -6.84M with a standard deviation of $ 119.27M.
The following table provides additional summary stats:
CF - Financing in the Market:
filtered constituents3.22K
min$ -367.1M
max$ 366M
average$ -6.84M
median$ 305K
std$ 119.27M